P J White1, L M Atley, C J Wraight
1Department of Pharmaceutical Biology and Pharmacology, Victorian College of Pharmacy, Monash University, Parkville 3052, Australia.
Antisense oligonucleotides show promise for treating psoriasis by targeting key proteins. Topical application is feasible in psoriatic skin due to its impaired barrier function, enabling drug delivery and target suppression.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: